bio personality
VIVEK VASUDEV KAMATH ASSUMES ROLE OF MANAGING DIRECTOR AT MSD
MSD in India has announced leadership change. K G Ananthakrishnan( KG) current Managing Director of MSD in India will retire in the beginning of 2017 and Vivek Vasudev Kamath has assumed the role of Managing Director Designate
from December 16, 2016. MSD in India operates its business in India through three legal entities, MSD Pharmaceuticals Private Limited, Organon( India) Private Limited, and Fulford( India) Limited.
Mr Kamath joined MSD in India in July 2012 and is currently the Business Unit Director for Cardiovascular Metabolics and Market Access. KG and Vivek will work together to ensure smooth transition of business responsibilities.
Announcing the leadership change, Jan Van Acker, President Asia Pacific Region, MSD said,“ I thank KG for his leadership and his contributions to MSD over the past ten years and congratulate Vivek on assuming the role of Managing Director of MSD in India. MSD has a robust succession planning process through which Vivek was identified to lead MSD in India and to deliver on our commitment to patients and communities in the Country. He has successfully led our Cardiovascular Metabolics and Market Access businesses and has fostered collaborative relationships with our customers and business partners, while delivering strong growth”.
PROF GAGANDEEP KANG AWARDED INFOSYS PRIZE 2016 FOR OUTSTANDING RESEARCH ON ROTAVIRUS
The Infosys Science Foundation( ISF) felicitated the winners of the Infosys Prize 2016 categories such as engineering and computer science, humanities, life sciences, mathematical sciences, physical sciences and social sciences in Bengaluru on January 07, 2016. The Infosys Prize carries prize money of Rs 65 lakh, a gold medal and a citation.
Recognizing the importance of her research on rotavirus, which kills more than two lakh children worldwide annually with India being among the worst hit, Gagandeep Kang, Executive Director of Translational Health Science and Technology Institute, Faridabad, won the award in the Life Sciences category. Her studies have shown that natural immunity to rotavirus infections is much lower in the Indian population, and through this, helped developed far more effective vaccines for the country. She was felicitated by Nobel Laureate Prof Venkatraman
Ramakrishnan who was the chief guest on the occasion.
Gagandeep Kang is a professor in the Department of Gastrointestinal Sciences at the Christian Medical College( CMC) in Vellore, India. She is Vice Principal for research and head of the Wellcome Trust Research Laboratory at CMC.
Dr Kang’ s research on paediatric diarrhoea focuses on rotavirus epidemiology, prevention and vaccine development. For molecular strain surveillance, she has built on her own work to develop a network of Indian enteric virology laboratories and the WHO Rotavirus Reference
Laboratory for SEARO, all of which have resulted in insights into the epidemiology, burden and transmission of rotavirus in India.
Dr Kang has published over 130 papers in national and international journals. She is an Associate Editor for PLoS Neglected Tropical Diseases and serves on several review committees for national and international research funding agencies.
BIOVOICENEWS. COM 43